The market for membrane bioreactors is segmented based on end-user type, such as municipal and industrial users, and end-user geography, for instance Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and the Americas.
In this line, in 2016, some studies and reports showed that the APAC region took the lead in terms of market share, owning 41.90%. On the other hand, the EMEA region's market share is approximately 31.34% and the Americas constitute 26.67% of the market.
APAC has the largest membrane bioreactors market. Developing economies such as India, China, Indonesia, and the Philippines are major contributors to growth in this market region. APAC is considered one of the most disaster-prone regions in the world: in 2013, thousands of people died from water-related disasters in the region, accounting for nine-tenth of the water-related deaths, globally. In addition to this, the public water supply system in the region is not as developed when compared to other countries such as the US, Canada, the countries in Europe, etc.
The membrane bioreactors market in the EMEA region has witnessed stable growth. Countries such as Saudi Arabia, the UAE, Kuwait, Algeria, Turkey, and Spain are major contributors to that growth rate. Scarcity of clean and fresh water is the key driver for the increasing demand for efficient water treatment technologies. In this regard, increased awareness about water treatment and safe drinking water is also driving the growth.
Ultimately, the Americas region has been witnessing major demand from countries including the US, Canada, Antigua, Argentina, Brazil, and Chile. The membrane bioreactor market has grown on account of stringent regulatory enforcement towards the safe discharge of wastewater. The demand for this emerging technology comes mainly from the pharmaceuticals, food & beverages, automotive, and chemicals industries.